Sonnet BioTherapeutic | DEF 14A: Definitive information statements
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Sonnet BioTherapeutic | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | S-3: Registration statement for specified transactions by certain issuers
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update
Sonnet BioTherapeutic | S-1: General form for registration of securities under the Securities Act of 1933
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
No Data